EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Metoclopramide to Prevent Pneumonia in Patients With Stroke and a Nasogastric Tube: Data From the PRECIOUS Trial

Wouter M Sluis iD, Jeroen C de Jonge iD, Hendrik Reinink iD, Lisa J Woodhouse iD, Willeke F Westendorp iD, Philip M Bath iD, Diederik van de Beek, H Bart van der Worp iD, PRECIOUS Investigators

Stroke · 2024

DOI: 10.1161/strokeaha.124.047582 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Stroke, 2024. Verfasst von Wouter M Sluis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Brain Center, University Medical Center Utrecht, Utrecht University, the Netherlands (W.M.S., J.C.d.J., H.R…. Hauptthemen laut MEDLINE: Metoclopramide, Intubation, Gastrointestinal, Pneumonia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union Horizon 2020 programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: A randomized trial suggested that treatment with metoclopramide reduces the risk of pneumonia in patients with acute stroke and a nasogastric tube. We assessed whether this finding could be replicated in a post hoc analysis of the randomized PRECIOUS trial (Prevention of Complications to Improve Outcome in Elderly Patients With Acute Stroke). METHODS: PRECIOUS was an international, 3×2 partial-factorial, randomized controlled, open-label clinical trial with blinded outcome assessment assessing preventive treatment with metoclopramide, paracetamol, and ceftriaxone in patients aged ≥66 years with acute ischemic stroke or intracerebral hemorrhage and a National Institutes of Health Stroke Scale score ≥6. In the present study, we analyzed patients who had a nasogastric tube within 24 hours after randomization. Patients who were allocated to metoclopramide (10 mg TID) were compared with patients who were not. Treatment was started within 24 hours after symptom onset and continued for 4 days or until discharge if earlier. The primary outcome was pneumonia in the first week after stroke. The score on the modified Rankin Scale after 90 days was a secondary outcome and analyzed with ordinal logistic regression. RESULTS: From April 2016 through June 2022, a total of 1493 patients were enrolled with 1376 included in this analysis, of whom 1185 (86%) had ischemic stroke and 191 (14%) had intracerebral hemorrhage. The first day after randomization, 329 (23.9%) patients had a nasogastric tube, of whom 156 were allocated to metoclopramide and 173 to standard care. Metoclopramide was not associated with a reduction of pneumonia (41.0% versus 35.8%; adjusted odds ratio, 1.35 [95% CI, 0.79–2.30]) or with poor functional outcome (adjusted odds ratio, 1.07 [95% CI, 0.71–1.61]). CONCLUSIONS: In patients with stroke who had a nasogastric tube shortly after stroke onset, metoclopramide for 4 days did not reduce pneumonia or have an effect on the functional outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetoclopramideIntubation, GastrointestinalPneumoniaHumansAgedMaleFemaleAged, 80 and overStrokeCeftriaxoneAcetaminophenIschemic StrokeCerebral HemorrhageTreatment Outcome

Stichwörter der Autor:innen

cerebral hemorrhagehumansischemic strokemetoclopramidepneumonia

Substanzen

MetoclopramideCeftriaxoneAcetaminophen

Autor:innen und Institutionen

  • Department of Neurology and Neurosurgery, Brain Center, University Medical Center Utrecht, Utrecht University, the Netherlands (W.M.S., J.C.d.J., H.R., H.B.v.d.W.).
  • Stroke Trials Unit, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, United Kingdom (L.J.W., P.M.B.).
  • Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, the Netherlands (W.F.W., D.v.d.B.).

ORCID-Profile: Wouter M Sluis, Jeroen C de Jonge, Hendrik Reinink, Lisa J Woodhouse, Willeke F Westendorp, Philip M Bath, H Bart van der Worp

Förderung

  • European Union Horizon 2020 programme

Zitieren

APA

Sluis, W. M., de Jonge, J. C., Reinink, H., Woodhouse, L. J., Westendorp, W. F., Bath, P. M., van de Beek, D., van der Worp, H. B., & PRECIOUS Investigators (2024). Metoclopramide to Prevent Pneumonia in Patients With Stroke and a Nasogastric Tube: Data From the PRECIOUS Trial. Stroke. https://doi.org/10.1161/strokeaha.124.047582

Vancouver

Sluis WM, de Jonge JC, Reinink H, Woodhouse LJ, Westendorp WF, Bath PM, et al. Metoclopramide to Prevent Pneumonia in Patients With Stroke and a Nasogastric Tube: Data From the PRECIOUS Trial. Stroke. 2024. doi:10.1161/strokeaha.124.047582

BibTeX
@article{Sluis2024,
  author = {Sluis, Wouter M and de Jonge, Jeroen C and Reinink, Hendrik and Woodhouse, Lisa J and Westendorp, Willeke F and Bath, Philip M and van de Beek, Diederik and van der Worp, H Bart and PRECIOUS Investigators, PRECIOUS Investigators},
  title = {Metoclopramide to Prevent Pneumonia in Patients With Stroke and a Nasogastric Tube: Data From the PRECIOUS Trial},
  journal = {Stroke},
  year = {2024},
  doi = {10.1161/strokeaha.124.047582}
}
Kostenlos starten →